Accuray Incorporated (ARAY) Stock

Accuray Incorporated specializes in the design, development, manufacturing, and distribution of advanced radiosurgery and radiation therapy systems worldwide. Established in 1990 and headquartered in Sunnyvale, California, the company is dedicated to pioneering innovative medical technology that enhances the treatment of tumors.

At the forefront of its offerings is the CyberKnife System, renowned for its robotic precision in stereotactic radiosurgery and stereotactic body radiation therapy. This system is instrumental in treating both primary and metastatic tumors located outside the brain, including those in sensitive areas such as the spine, breast, kidney, liver, lung, pancreas, and prostate.

Accuray also provides the TomoTherapy System, featuring the Radixact System, which integrates radiation treatment planning, delivery, and data management. This advanced system empowers clinicians to deliver highly precise treatments efficiently, catering to approximately 50 patients daily.

Committed to comprehensive customer support, Accuray offers a range of services including installation, training, and ongoing professional support post-contract. The company markets its products directly to hospitals and standalone treatment facilities through its dedicated sales organization in the United States, and internationally through distributors and sales agents. Accuray continues to lead the industry with its commitment to advancing oncological care through cutting-edge technology and personalized treatment solutions.